Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 41Esophageal Squamous Cell Carcinoma 17Carcinoma, Squamous Cell 5Neoplasms 4Adenocarcinoma 4Sarcopenia 2Radiation Injuries 2Obesity 2Anastomotic Leak 2Stomach Neoplasms 1Respiratory Insufficiency 1Radiation Pneumonitis 1Radiation Fibrosis Syndrome 1Pulmonary Fibrosis 1Postoperative Complications 1Pneumonia 1Pathologic Complete Response 1Pain, Postoperative 1Osteoporosis 1Obesity, Abdominal 1Neoplastic Cells, Circulating 1National Cancer Center/Cancer Hospital 1Motor Activity 1Margins of Excision 1Lymphatic Metastasis 1Loco-regional Esophageal Cancer 1Esophageal Diseases 1Deglutition Disorders 1Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1Brain Neoplasms 1

Interventions

Radiotherapy 1Paclitaxel 1Fluorouracil 1Esophagectomy 1Cisplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Loco-regional Esophageal Cancer × Esophagectomy × Clear all
NCT00570531 2016-05-26

Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma

University of Michigan Rogel Cancer Center

Phase 2 Terminated
6 enrolled 5 charts
Gastrointestinal

Loco-regional Esophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡